Sunday, 19 July 2020

Tele-Intensive Care Unit (ICU) Market Overview With Detailed Analysis, Competitive Landscape, Forecast To 2024

Tele-Intensive Care Unit (ICU) Market Scenario

Tele-Intensive Care Units (ICU) are advanced systems used for the treatment of critically ill patients by using off-site clinical resources. It is a part of telemedicine which is used for the exchange of medical information for conducting various medical activities such as monitoring, treatment, and rehabilitation.
The Global Tele-Intensive Care Unit (ICU) Market Growth is accounted for USD 1820 Million in 2018 and expected to register 16.4% CAGR during the forecast period (2019–2024).
The rising prevalence of chronic disorders such as cancer, increasing geriatric population, technological advancements in the healthcare sector and increasing cases of patients affected by neurological disorders across the world are expected to drive the growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), In the year 2016, more than 10.4 million cases of tuberculosis were registered in the world, and 1.7 million deaths occurred due to tuberculosis in the year 2016. Moreover, rising R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market.
The lack of adequate reimbursement policy and high costs involved in the establishment of these centers may hamper the growth of the market during the assessment period.

Tele-Intensive Care Unit (ICU) Market Segmentation

The global Tele-Intensive Care Unit (ICU) market has been segmented on the basis of component and type of management.
On the basis of component, the market has been classified as hardware and software. The market, by hardware, has been further segmented into the computer system, communication lines, physiological monitors, therapeutic devices, video feeds, and others.
Based on the type of management, the market has been segmented into intensivist, open, co-managed, open with a consultant, and other types of management.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Tele-Intensive Care Unit (ICU) market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European Tele-Intensive Care Unit (ICU) market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 
The Tele-Intensive Care Unit (ICU) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Tele-Intensive Care Unit (ICU) market in the Middle East & Africa has been segmented into the Middle East and Africa.

Tele-Intensive Care Unit (ICU) Market Company Profiles

  • SOC Telemed
  • Intouch Technologies, Inc.
  • Koninklijke Philips N.V.
  • Advanced Icu Care
  • UPMC
  • Banner Health
  • Teleicucare
  • Eagle Telemedicine
  • Apollo TeleHealth Services
  • Inteleicu
  • Others
Tele-Intensive Care Unit (ICU) Regional Market Summary
The Americas are likely to dominate the global Tele-Intensive Care Unit (ICU) market owing to the technological advancements related to healthcare in the region, the surge in cases of chronic disorders, and an increasing number of hospitals in the regions.  According to the report published by the American Hospital Association, more than 5200 community hospitals were present in the US in the year 2018, out of which 3,387 belongs to urban areas, and 1875 were from rural areas.
The European market is expected to be the second-largest Tele-Intensive Care Unit (ICU) market. The market growth in this region can be attributed to the increasing demand of healthcare systems which can provide real-time data, rising cases of neurological disorders in the European region, and government funding and support of the healthcare sector along with the increasing research and development. Moreover, favorable reimbursement policies in European countries are contributing to the growth of the market in this region. According to the European Academy of Neurology, neurological disorders are increasing in Europe, and in the year 2017, more than 220 million European population was affected by neurological complications.
Asia-Pacific is expected to be the fastest-growing Tele-Intensive Care Unit (ICU) market during the forecast period owing to the increasing geriatric population, rising investments in healthcare, and expansions by market players in the region. Also, countries such as India and China are considering the fastest growing region due to the presence of a huge patient population. Moreover, the government of these countries is open to adopting new technology and the best treatment option from a developed country.
The market in the Middle East & Africa is expected to account for the smallest share of the global Tele-Intensive Care Unit (ICU) market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Posted by at No comments:

Global Gene Expression Analysis Market 2020 Insights Business Opportunities, Current Trends And Restraints Forecast 2023

Gene Expression Analysis Market Overview
As per Market Research Future (MRFR) analysis, the global gene expression analysis market report is estimated to hold a market value of USD 3.250 million with a CAGR 9.1% from 2018 to 2023 (forecast period). 
Gene expression analysis is a research focused on functional genomics that broadens the scope of the study of genes and gene transcripts. Synthesizing functional gene products like functional RNAs and protein species provides insights into how an intact organism survives when a particular gene is missing. 
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7805
Gene Expression Analysis Market Dynamics
Personalized medicine is becoming more popular, with an increasing number of genetic disorders. In addition, increasing awareness of personalized medicine is expected to drive growth over the forecast period. As per the data published by Foley & Lardner LLP, the Food and Drug Administration (FDA) approved 16 new personalized medicinal products in 2017. Moreover, the advancement of genomic databases increased government support for genomics, and growth in personalized medicine is likely to drive the market. 
However, the shortage of skilled labor and the high cost of instruments may inhibit market growth during the forecast period. 
Gene Expression Analysis Market Segmentation
The global market for gene expression analysis has been segmented into product, consumables, instruments, services, application, and end-user.
Based on the product, the global market for gene expression analysis has been segmented into consumables and instruments.
Based on consumables, the global market for gene expression analysis has been further segmented into reagents and DNA chips.
Based on instruments, the global market for gene expression analysis has been further segmented into next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, Sanger sequencing, and others.
Based on services, the global market for gene expression analysis segmented into gene expression profiling services, sequencing services, bioinformatics solutions, and others.
Based on the application, the global market for gene expression analysis has been segmented into drug discovery, diagnosis, research, and others.
Based on end-user, the global market for gene expression analysis has been segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and others. 
Gene Expression Analysis Market Regional Analysis
Regionally, the global gene expression analysis market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas are predicted to dominate the global market for gene expression analysis due to increasing research activities and the increasing popularity of gene expression tests. In addition, the well-developed healthcare sector is predicted to improve the American market for gene expression analysis.
Europe is predicted to hold the second-largest position in the global market for gene expression analysis. Market growth in this region is due to the availability of research funding.
The Asia Pacific is projected to be the fastest-growing region on the market due to rising investment by governments in genomics and continuously developing economies. As stated in the report published by the International Journal of Social and Developmental Concerns in October 2017, the growth of public primary and secondary care facilities in Malaysia has decreased over the last few years and has not kept pace with modern urbanization. These factors, therefore, restrict the growth of the market in this region. 
The Middle East and Africa are estimated to have the least market share. 
Gene Expression Analysis Market Key Players
Some of the significant participants in the global gene expression analysis market are GENERAL ELECTRIC COMPANY, Illumina, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Pacific Biosciences of California, Inc., Oxford Gene Technology, BGI, PerkinElmer Inc., Agilent Technologies, Inc., QIAGEN, Eurofins Scientific, Genotypic Technology Pvt Ltd, Danaher, Macrogen Inc. 
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Equipment Trends & Assessment
Chapter 5. Market Factor Analysis
...TOC Continued
LIST OF TABLES
Table 1 Global Gene Expression Analysis Market Synopsis, 2018–2023
Table 2 Global Gene Expression Analysis Market Estimates And Forecast, 2018–2023 (USD Million)
Table 3 Global Gene Expression Analysis Market, By Region, 2018–2023 (USD Million)
Table 4 Global Gene Expression Analysis Market, By Product, 2018–2023 (USD Million)
Table 5 Global Gene Expression Analysis Market, By Services, 2018–2023 (USD Million)
Table 6 Global Gene Expression Analysis Market, By Applications, 2018–2023 (USD Million)
....Continued
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Market Structure For Global Gene Expression Analysis Market
Figure 3 Market Dynamics For Global Gene Expression Analysis Market
Figure 4 Global Gene Expression Analysis Market Share, By Product, 2017
Figure 5 Global Gene Expression Analysis Market Share, By Services, 2017
Figure 6 Global Gene Expression Analysis Market Share, By Applications, 2017
....Continued
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/gene-expression-analysis-market-7805 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Posted by at No comments:

Global Robot-Assisted Surgical Systems Market 2020 Insights Business Opportunities, Current Trends And Restraints Forecast 2023

Market Insights:
The increasing need for automation in the healthcare industry and the shifting trend towards advanced robotic surgeries is anticipated to fuel the growth of the market. The high initial costs and adverse reports stand is expected to hamper the growth of the market.
Robot-assisted surgical systems industry will witness a widespread adoption since the introduction of the da Vinci surgical system by Intuitive Surgical Inc. After the system got FDA approval in 2000, da Vinci surgical system became the most widely-used surgical robot in the United States and Europe helping many cases to witness reduced length of hospital stays and lower rates of infection.
The Global Robot-Assisted Surgical Systems Market is projected to grow significantly over the forecast period. It is estimated that the global robot-assisted surgical systems market is expected to register a CAGR of ~10% during the forecast period of 2018–2023.
The global robot-assisted surgical systems market is conquered by several players. The key players are involved in new product launches, as well as strategic collaborations to brace their position in the market. For instance, in May 2015, Medtech expanded its presence in Asia with the sales of three ROSA Surgical Robots during April. This initiative is anticipated to open new avenues for the firm to cater to the untapped markets in this region.
Regional Market Summary
It is projected that the Americas dominated the global robot-assisted surgical systems market owing to the growth of the market in the North American region. This is largely attributed to factors such as well-established healthcare infrastructure and the increase in adoption of robotic surgical systems across various healthcare settings will support market growth in this region. Europe is expected to hold the second largest robot-assisted surgical systems market share in the robot-assisted surgical systems market owing to the introduction of advanced robot-assisted laparoscopic procedures and quality of treatment of existing and new medical indications.
Asia-Pacific was projected to be the fastest growing region for the global robot-assisted surgical systems market. With the growth of the overall robotics market in the region headed by technology giants like Japan and China, the availability of medical robots has also increased. In 2017, a robot performed the world’s first automated dental implant in China. The Middle East and Africa holds the least share in the global robot-assisted surgical systems market due to the presence of economically diverse countries, and fewer initiatives taken by the government.
Key Players
  • Stryker Corporation (MAKO Surgical Corp.),
  • Renishaw Plc,
  • Varian,
  • Accuray,
  • Intuitive Surgical Inc,
  • Health robotics S.R.L,
  • Smith & Nephew Plc. (Blue Belt Technologies, Inc.),
  • Auris Surgical Robotics, Inc. (Hansen Medical Inc.),
  • KUKA AG,
  • Mazor Robotics,
  • Medtronic plc,
  • THINK Surgical Inc.,
  • Zimmer Biomet Holdings Inc.,
  • Transenterix,
  • Verb Surgical,
  • Titan Medical,
  • Microbot Medical,
  • Medrobotics
Segmentation
The Global Robot-Assisted Surgical Systems Market is segmented on the basis of product, application, and end user.
Surgical robots are divided into orthopedic surgical robots, robotic neurosurgical systems, and laparoscopy robotic systems. Orthopedic Surgical Robots is divided into an iBlock surgical system, Robodoc surgical system, Navio PFS surgical system, MAKO RIO surgical system, and Stanmore Sculptor surgical system. Neurosurgical Robotic Systems is divided into Pathfinder surgical system, NeuroMate surgical system, and Renaissance surgical system. Laparoscopy Robotic Systems is divided into FreeHand endoscope holder system, Da Vinci robotic surgery system, Telelap ALF-X surgical system, and Steerable Robotic Catheters.
The robot-assisted surgical systems market by product is categorized into surgical robots, rehabilitation robots, non-invasive radiosurgery robots, hospital and pharmacy robots, and emergency response robotic systems.
Rehabilitation robots are categorized into assistive robots, prosthetics, orthotics, therapeutic robots, and robotic exoskeleton systems. Hospital and pharmacy robots are categorized into telemedicine robots, IV robots, pharmacy robots, and cart transportation robots.
Based on application, the robot-assisted surgical systems market is segmented into neurology, orthopedics robotic systems, laparoscopy, and special education.
On the basis of end user, the market is segmented into healthcare providers, healthcare payers, and others.
On the basis of region, the global robot-assisted surgical systems market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. The robot-assisted surgical systems market in the Middle East and Africa has been segmented into the Middle East and Africa.
Posted by at No comments:

Live Cell Encapsulation Market Growth Analysis, Industry Trends, And Forecast By 2023

Global Live Cell Encapsulation Market Research Report: By Manufacturing Technique (Simple Dripping, Electrostatic Dripping, & Others), Polymer Type (Alginate, HEMA-MMA, Chitosan, PAN-PVC, & Others), Application (Drug Delivery & Others)-Forecast till 2023
The Global Live Cell Encapsulation Market Growth is expected to boost significantly over the forecast period. It is estimated that the global live cell encapsulation market is expected to register a CAGR ~ 3.22% during the forecast period of 2018 to 2023, with an estimated market value of USD 249.87 million in 2017.
The global market is driven by factors such as rising demand for clinical efficacy of cell encapsulation technologies and growing awareness related to the clinical role of encapsulated cells to treat different chronic diseases. Additionally, encapsulation provides the durability and stability of the nutrient during handling and storage. Thus, such benefits of this technique are luring the competitors to enter the industry with new Live Cell Encapsulation Market Trends.
On the other hand, the lack of skilled technicians, ethical issues, and unaffordability of research organizations and small-scale companies in certain economies is restraining the growth of live cell encapsulation market. Moreover, the availability of high-quality raw material is also restraining the growth of the market. Nevertheless, changes in regulatory policies and rise in demand for effective therapies to treat complicated disorders is expected to reduce the impact of barriers over the forecast period.
Moreover, major companies in the market are involved in strategic collaborations to brace their position in the market. For instance, in August 2018, Balchem Italia S.r.l., a wholly owned subsidiary of Balchem Corporation, acquired Bioscreen Technologies, S.r.l., a privately held manufacturer of encapsulated and fermented feed nutrition ingredients. With this, the company aims to expand its position in the market.
Segmentation
The Global Live Cell Encapsulation Market has been segmented into manufacturing technique, polymer type, and application. The market, based on manufacturing technique, has been segmented into simple dripping, electrostatic dripping, coaxial airflow, rotating disk atomization, and others. The market, by polymer type, has been further segmented into alginate, HEMA-MMA, Chitosan, silica, cellulose sulfate, PAN-PVC, and others. The market, by application, has been segmented into drug delivery, regenerative medicine, cell transplantation, and others. The drug delivery segment is expected to hold a major share owing to the increasing use of live cell encapsulation techniques in drug delivery systems. The segment of regenerative medicine is expected to be the fastest growing segment due to the rising trend and benefits of encapsulation in the tissue engineering field.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The live cell encapsulation market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European live cell encapsulation market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The live cell encapsulation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The live cell encapsulation market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Balchem Corporation, Evonik Industries, Merck KGaA, BÜCHI Labortechnik AG, Lycored, Blacktrace Holdings Ltd., Living Cell Technologies, Reed Pacific Pty Limited, MiKroCaps, Biotime, Inc., Neurotech Holdings, LLC, Sernova Corporation, Encapsys, LLC, Sigilon Therapeutics, Inc., and Viacyte, Inc. are some of the key players in the global live cell encapsulation market.
Regional Market Summary
Geographically, the Americas is expected to dominate the global live cell encapsulation market due to the increasing per capita healthcare expenditure, and the heavy adoption of new technology.
Furthermore, rising expenses in research and development by healthcare bodies and the government is anticipated to drive the growth of the market in this region. Apart from this, increasing applications of regenerative medicine in the US is expecting to push the growth of live cell encapsulation market. For instance, According to the National Institutes of Health (NIH), approximately 5,00,000 Americans benefit from a transplant each year.
Europe showed a considerable amount of growth in the global live cell encapsulation market. The market growth in this region is because of the presence of a well-established healthcare system and increase in chronic diseases. For instance, according to cancer research UK, there were approximately 9, 921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for the use of next-generation sequencing as well as increase the market demands for monoclonal bodies and cellular research. These factors are expected to have a positive impact on the live cell encapsulation market.
Asia-Pacific is expected to have a sturdy growth rate during the forecast period owing to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. However, less capital investment is restricting the market growth of this region.
On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. Moreover, the limited adoption of advanced healthcare facilities and limited access to treatment facilities is also expected to drive the growth of the market in the near future.
Posted by at No comments:

Soft Tissue Repair Market Share, Global Insights And Gross Margin Analysis 2023

Global Soft Tissue Repair Market Research Report: By Product (Fixation, Tissue Patch/Match, & Others), Application (Orthopedic, Skin Repair, Hernia, Vaginal Sling, Dental Reconstruction), End User (Hospitals, Clinics & others)—Global Forecast till 2023
Market Insights:
The Global Soft Tissue Repair Market insights expects to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 5200 million in 2017 and is projected to register a CAGR of 6.2% over the forecast period.
Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market.
The xenograft implant is designed for the surgical repair of damaged or ruptured membranes. The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market growth. For instance, in 2016, Colorado Therapeutics received FDA approval for its xenograft implant.
However, the high cost of advanced equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period.
Key Players
Some of the key players in the global soft tissue repair market are Stryker Corporation, C.R. Bard, Inc., Arthrex, Inc., Integra LifeScience Corporation, Depuy Synthes, Smith & Nephew plc, Allergan Plc., Athersys, Inc., CryoLife, Inc., Medtronic Plc., Organogenesis Inc., Zimmer Biomet Holdings, Inc., Lifenet Health, Inc., American Medical Systems Inc., U.S. Stem Cell, Inc., Wright Medical Group, Inc., Isto Biologics, and others.
Segmentation
The global soft tissue repair market is segmented based on product, application, end user, and region.
the global market for soft tissue repair, by product, is segmented into fixation products, tissue patch/match, laparoscopic instrument, and others. The fixation products segment is further classified as a suture, suture anchors, and interference screw. The tissue patch/match segment is further classified as biological, and synthetic. The biological segment includes allograft and xenograft.
Based on application, the market is segmented into orthopedic surgery, skin repair, hernia repair, vaginal sling repair, dental reconstruction, cardiovascular surgery, breast reconstruction, and others.
Based on end user, the market is segmented into hospitals, clinics, research & academic institutes, and others.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.
The soft tissue repair market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European soft tissue repair market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The soft tissue repair market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The soft tissue repair market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas dominated the global market for soft tissue repair owing to the increasing healthcare expenditure presence of major market players and rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058.
In 2017, it was estimated that Europe stood second in the global soft tissue repair market. Robust research and development (R&D) sector along with the availability of funding opportunities in research and innovation will support the market growth.
Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to increasing demand for medical technology, growing health awareness, and growing aging population coupled with the rising prevalence of orthopedic diseases in India, Japan, and Australia. For instance, according to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), in 2016, around 12.4% of the population in the region was 60 years or older and is projected to reach to more than 1.3 billion by 2050.
On the other hand, the Middle East and Africa held the least share in the global soft tissue repair market due to the low economic development, especially within the African region.
Posted by at No comments:

Global Superdisintegrants Systems Market 2020 Business Insights & Deep Analysis To 2023 By World’s Top 10 Key Players

Market Scenario:
The Global Superdisintegrants Market is anticipted to grow at an optimistic CAGR of 7.9% during the forecast period from 2018 to 2023. Disintegrants are substances which are included in drug formula to allow proper disintegration of the capsule or tablet into easily dissolvable particles. This plays a vital function in the fast absorption of medicine which increases its efficacy. Superdisintegrants are slightly modified disintegrants which offer higher efficiency than their traditional counterparts. Observed to have valued at USD 371 Mn in 2017, the global superdisintegrants market size is poised to appreciate to reach an estimated value of USD 576.2 Mn by the end of 2023.
The pharmaceutical industry is growing at breakneck speed, becoming a significant part of the healthcare sector. This is primarily due to rising populations of both geriatric patients and pediatric patients. Superdisintegrants are helpful for treatment of patients from this demographic as these tablets are easier to swallow. The growth of these demographics is expected to drive market growth. Moreover, generic drugs are in high demand as patents have begun to run out on several popular drug brands, thus opening up the pharmaceutical industry for increased entry of competition and a rise in the manufacturing of generic drugs, thus driving superdisintegrants market demand.
Emerging markets represent significant opportunity as the healthcare sectors in these regions are growing at a swift pace. Moreover, large patient pools are in these countries are expected to increase demand for fast-acting medication. Market players are likely to establish themselves in the region in an effort to leverage the opportunities available in emerging economies.
Players Covered
Prominent market participants that have been profiled in the report include Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC
Market Segmentation
MRFR's analysis of the various segments in the market has been performed on the basis of type, formulation, therapeutic area, and region. Types of superdisintegrants have been segmented into synthetic superdisintegrants, natural disintegrants, and others. Among these, the synthetic superdisintegrants segment has been widely used, making it the most significant market segment. However, the natural superdisintegrants segment is growing at a truly rapid pace due to the growing demand for natural ingredients.
Formulations which include superdisintegrants have been segmented into tablets and capsules. Tablets govern a majority share of the total market, while the capsules segment is expected to grow at the highest CAGR during the review period.
Therapeutic areas where superdisintegrants are used have been segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, inflammatory diseases, hematological diseases, and cardiovascular diseases. Among these segments, the gastrointestinal diseases segment is at the forefront of market growth due to the demand for fast acting medicine for these types of diseases. Meanwhile, the oncology segment is growing rapidly and is expected to display the highest CAGR over the forecast period.
Regional Analysis
Led by the U.S, the Americas have captured the largest share of the global superdisintegrants market. The presence of a developed healthcare sector as well as several important market players that have and continue to influence growth and contribute to the sizeable share that this regional market possesses. The region also has a high demand for drugs for many chronic diseases where superdisintegrants are required due to the prevalence of such diseases.
The Asia Pacific superdisintegrants market is likely to grow at the highest pace due to the concentration of rapidly emerging markets in the region. China, Japan, India, and several other country-level markets have a high demand for drugs for chronic diseases. The APAC regional market has several avenues for growth that are expected to open up in the coming years. The regions rapidly growing healthcare sector and the presence of a number of contract manufacturing organizations for pharmaceuticals is likely to have a positive impact on the market.
Posted by at No comments:

Male Breast Cancer Market Global Analysis, Size, Share, Trends, And Forecast 2020 To 2023

Global Male Breast Cancer Market Research Report: By Type (Infiltrating Ductal Carcinoma, Inflammatory Breast Cancer, Paget Disease, Ductal Carcinoma), by Diagnosis (Mammography, Biopsy, Pet Scan, Others), by Treatment (Local, Systemic) – Forecast Till 2023
Market Scenario:
Although breast cancer is common in women, even men suffer from the same. Men also have breast tissues and cancer starts when these tissues start to grow out of control. The breast ducts and glands present in men are not functional, but cancer in these areas can spread when cancer cells enter the blood or lymph system and are carried in the whole body. Men who have suffered from cancer before and undergone radiation therapy are at a high risk of suffering from male breast cancer.
The rising geriatric population and an increasingly obese population resulting in high levels of estrogen in males are expected to drive the growth of the market during the forecast period. According to an article published by the National Cancer Institute in April 2018, most of the men who suffer from breast cancer are 60 to 70 years old. Additionally, the rising healthcare expenditure is likely to boost the market growth. On the other hand, lack of knowledge of the disease and high cost of treatment may hinder the growth of the market during the forecast period.
The global male breast cancer treatment market is expected to grow slowly at a CAGR of ~ 3.6% during the forecast period from 2018 to 2023. Male breast cancer is caused when the breast tissues of males start growing out of control and become cancerous.
Numerous factors such as increasing obese population and growing geriatric population are expected to drive the growth of the market. For instance, in July 2017, the Bristol-Myers Squibb Company announced a broad clinical collaboration with Clovis Oncology for evaluating the combination of cancer drugs Nivolumab and Rucaparib in Phase 2 and Phase 3 clinical trials in multiple tumor types.
Moreover, favorable healthcare expenditures boost the growth of the market. However, lack of knowledge and the high cost of treatments may hamper the market growth during the assessment period.
Key players
Achieve Life Sciences, Inc., Pfizer, Eli Lilly and Company, Bristol-Myers Squibb Company, F. Hoffmann-La Roche, Sanofi, Novartis AG, BioNumerik Pharmaceuticals Inc., Seattle Genetics, Inc., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., AstraZeneca, Accord Healthcare, and Bayer AG are some of the key players in the global male breast cancer market.
Segmentation
The global male breast cancer market has been segmented into type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into, ductal carcinoma in situ, Paget’s disease of the nipple, inflammatory breast cancer, and infiltrating ductal carcinoma.
The market, by diagnosis, has been segmented into, mammography, biopsy, PET scan, CT scan, MRI scan, and other tests. On the basis of diagnosis, biopsy is anticipated to record the largest growth owing to its accuracy of diagnosing the disease. It is also expected to be the fastest growing segment.
By diagnosis, biopsy is further segmented into, fine needle aspiration biopsy, core biopsy, and excisional biopsy.
The market, by treatment, has been segmented into, local treatments and systemic treatments.
By treatment, local treatments are further segment into, surgery and radiation therapy.
Surgery is further segmented into, mastectomy, breast-conserving surgery, and lymph nodes biopsy.
By treatment, systemic treatments are further segmented into, chemotherapy, hormone therapy, and targeted therapy.
Hormone therapy is further segmented into, using drugs and orchiectomy (castration).
Chemotherapy is further segmented into, adjuvant therapy and neoadjuvant therapy.
Targeted therapy is further segmented into, for HER2 positive breast cancer, for hormone receptor-positive breast cancer, and for cancer with BRCA mutations.
The European male breast cancer market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 
The male breast cancer market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The male breast cancer market in the Middle East and Africa has been segmented into the Middle East and Africa.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The male breast cancer market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global male breast cancer market owing to the changing lifestyle and rising prevalence of breast cancer. According to an article published by, the American Cancer Society in April 2018, the lifetime risk of getting breast cancer in men is approximately 1 in 833. Europe is expected to hold the second largest position in the global male breast cancer market. The market growth in this region is attributed to the growing prevalence of rare cancers, the availability of funds for research, and increasing healthcare expenditure. According to the Cancer Research UK, 371 new cases of male breast cancer were reported in 2015 in the UK.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising awareness regarding early symptoms of cancer and government support for healthcare facilities. According to a study published by the European Society for Medical Oncology in January 2016, there were 4.3 million new cases of cancer in China in 2015.
On the other hand, the Middle East and Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle Eastern region due to growing government initiatives for the healthcare sector.
Posted by at No comments:
Subscribe to: Posts (Atom)